Abstract
Objectives The aim of this study was to clarify which workers’ symptoms led to unemployment during the COVID-19 pandemic.
Methods This was a prospective cohort study using questionnaires about COVID-19 administered to Japanese workers. A baseline survey conducted in December 2020 was used to determine workers’ health history. Unemployment since the baseline survey was ascertained with a follow-up survey in December 2021. The odds ratios (ORs) of unemployment were estimated using a multilevel logistic model with adjusted covariates nested in prefecture of residence.
Results Males (n = 8,682) accounted for 58.2% of the total sample (n = 14,910), and the mean age was 48.2 years. Multivariate analysis showed that workers with “pain-related problems,” “limited physical movement and mobility,” “fatigue, loss of strength or appetite, fever, dizziness, and moodiness,” “mental health problems,” or “sleep” had a greater probability of resigning for health reasons, resigning for all reasons other than retirement, and being unemployed. Those with “skin, hair, and cosmetic concerns” or “eye-related matters” had a greater probability of becoming unemployed.
Conclusions We identified an association between workers’ symptoms and resignation or unemployment, with different symptoms having different ORs. Furthermore, there were differences in the associations among the effects of symptoms, work dysfunction, resignation/unemployment, and attitudes of others. Preventive interventions to help workers resolve or improve their symptoms could prevent their becoming unemployed or resigning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported and partly funded by the research grant from the University of Occupational and Environmental Health, Japan (no grant number); Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004); Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), and Hitachi Systems, Ltd. (no grant number) and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference nos. R2-079 and R3-006).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data supporting the findings of this study are available from the corresponding author, Tomohisa Nagata, upon reasonable request.
